Amdocs Limited (NASDAQ:DOX) Shares Bought by Affinity Investment Advisors LLC

Affinity Investment Advisors LLC lifted its holdings in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 19.3% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,605 shares of the technology company’s stock after acquiring an additional 1,393 shares during the quarter. Affinity Investment Advisors LLC’s holdings in Amdocs were worth $753,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. State Board of Administration of Florida Retirement System lifted its position in Amdocs by 7.9% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 166,927 shares of the technology company’s stock worth $16,030,000 after acquiring an additional 12,178 shares in the last quarter. Boston Trust Walden Corp lifted its holdings in Amdocs by 17.0% in the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company’s stock worth $48,803,000 after buying an additional 89,726 shares in the last quarter. SG Americas Securities LLC boosted its position in Amdocs by 402.4% in the 2nd quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company’s stock valued at $12,230,000 after buying an additional 124,122 shares during the last quarter. Sargent Investment Group LLC acquired a new stake in shares of Amdocs during the second quarter valued at about $289,000. Finally, Acadian Asset Management LLC increased its position in shares of Amdocs by 22.7% during the first quarter. Acadian Asset Management LLC now owns 1,395,894 shares of the technology company’s stock worth $126,119,000 after acquiring an additional 258,343 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Trading Up 0.4 %

NASDAQ:DOX opened at $88.06 on Friday. The company has a market cap of $10.35 billion, a PE ratio of 20.29, a P/E/G ratio of 1.43 and a beta of 0.74. The business’s 50 day moving average is $87.42 and its two-hundred day moving average is $83.67. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $94.04.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The technology company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.02. Amdocs had a net margin of 10.21% and a return on equity of 17.89%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.25 billion. During the same quarter in the prior year, the firm earned $1.41 EPS. The company’s revenue for the quarter was up 1.1% compared to the same quarter last year. On average, analysts predict that Amdocs Limited will post 5.67 EPS for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Monday, September 30th were given a dividend of $0.479 per share. The ex-dividend date was Monday, September 30th. This represents a $1.92 dividend on an annualized basis and a yield of 2.18%. Amdocs’s dividend payout ratio is currently 44.24%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on DOX shares. StockNews.com upgraded Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 25th. Stifel Nicolaus began coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 price target for the company. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Amdocs currently has an average rating of “Buy” and an average target price of $102.00.

Read Our Latest Report on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

See Also

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.